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dase (MPO) genes (Zhu et al., 1994) are also DNaseI
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hypothesized that genes related to multiple lineagesSummary
may be promiscuously expressed preceding commit-
ment in what has been termed “priming” (Cross andWe demonstrate here that “promiscuous” expression
Enver, 1997; Enver and Greaves, 1998). This is formallyof myeloid or lymphoid genes precedes lineage com-
similar to the formation of “sterile transcripts” of as yetmitment in hematopoiesis. Prospectively purified sin-
unrearranged Ig chains and TCR subgenic coding se-gle common myeloid progenitors (CMPs) coexpress
quences found in cells committed to the Ig and TCRmyelo-erythroid but not lymphoid genes, whereas sin-
rearrangement processes (Alt et al., 1982; Nelson etgle common lymphoid progenitors (CLPs) coexpress
al., 1983). According to the priming model, one of theT and B lymphoid but not myeloid genes. Genes unre-
important events in lineage commitment includes thelated to the adopted lineage are downregulated in bi-
transcriptional abrogation of master control genes inpotent and monopotent descendants of CMPs and
the unselected lineages.CLPs. Promiscuous gene expression does not alter the
Several lines of evidence support this hypothesis. Bybiological potential of multipotent progenitors: CMPs
using highly sensitive single-cell RT-PCR assays, a frac-with an activated endogenous M lysozyme locus yield
tion of cells of the FDCP-mix line coexpress a varietynormal proportions of myelo-erythroid colonies, and
of genes related to granulocyte/monocyte (GM) andCLPs expressing the pre-T cell receptor  gene differ-
megakaryocyte/erythrocyte (MegE) lineages, includingentiate into normal numbers of B cells. Thus, the ac-
MPO and-globin (Hu et al., 1997). In normal hematopoi-cessibility for multiple myeloid or lymphoid programs
esis, the coexpression of MPO and -globin was alsopromiscuously may allow flexibility in fate commit-
found in a fraction of human LineageCD34 cells (Huments at these multipotent stages.
et al., 1997) and mouse intraembryonic hematopoietic
progenitors in the aorta-gonad-mesonephros region
Introduction
(Delassus et al., 1999). Single CD34CD38 human cells
coexpress multiple transcription factors, such as the
Hematopoiesis is a paradigmatic system for progressive MegE-related factors GATA-1 and NF-E2 as well as the
restriction of cell fate potentials from hematopoietic GM-related PU.1 transcription factor (Cheng et al.,
stem cells (HSCs) to lineage-restricted progenitors that 1996). However, it is unclear whether cells with lineage-
produce all lineages of mature blood cells. This progres- promiscuous expression actively contribute to multilin-
sive restriction and the genetic programs underlying it eage hematopoiesis in a physiological setting. In these
may serve as a model for developmental events com- studies, culture-adapted immortalized cells or enriched
mon to other systems. A fundamental question is how but not functionally purified subsets were used, or func-
the progeny of multipotent cells adopts one fate from a tional analyses of target cells were not performed to-
choice of several. Lineage commitment and subsequent gether with gene expression analyses. In another study,
differentiation of multipotent cells likely involves the se- where the expression of lineage-affiliated genes was
lective activation and silencing of particular gene ex- tested in single progenitors of differentiation potential
pression programs. known by tracking the fate of their siblings in vitro, lin-
It is still unclear whether such programs are triggered eage-affiliated genes, including MPO, M lysozyme, and
by extrinsic instructive signals (Kondo et al., 2000; Met- -globin genes, were found to be hierarchically but not
calf, 1998, 1999) in a cell-autonomous fashion (Akashi promiscuously regulated (Brady et al., 1995).
A potential problem in these studies is that, for uncom-
mitted progenitors, documentation of “commitment”5 Correspondence: koichi_akashi@dfci.harvard.edu
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usually requires a lineage readout that involves multiple away from multipotentiality is made at the lymphoid
(CLPs) versus myeloid (CMPs) branching point. CMPsfactors, such as proliferation, survival, and differentia-
tion, within the limitations of particular assay systems. can generate all myeloid lineage cells, giving rise to
GMPs and MEPs. GMPs and MEPs differentiate exclu-Since lineage readouts from multipotent cells may occur
at random, at least in vitro (Ogawa, 1993; Suda et al., sively into the GM and MegE lineages, respectively
(Akashi et al., 2000a). Single CLPs can give rise to both1984), the functional outcomes do not necessarily reflect
the full lineage potentials of target cells. Furthermore, T and B cells (Kondo et al., 1997). Therefore, the second
commitment decision might occur at the GM versusit is also possible that lineage promiscuity may represent
cells with deregulated gene expression patterns that MegE branchpoint in the myeloid pathway and at the B
versus T cell branchpoint in the lymphoid pathway.may be developmentally neglected in normal hemato-
poiesis. In fact, in the embryonic pancreas, cells coex-
pressing glucagon and insulin (Teitelman et al., 1993) Expression of Lineage-Affiliated Genes in
do not necessarily contribute to the development of Prospectively Purified Progenitor Populations
glucagon-secreting  cells or insulin-secreting  cells We first tested the expression of a variety of lineage-
(Herrera et al., 1994). affiliated genes in 200–500 cells of each progenitor sub-
Thus, it is important to analyze genetic programs in set by conventional RT-PCRs. As summarized in Table
prospectively purified functionally defined progenitors 1, all myeloid genes tested were expressed in both HSCs
in order to understand the molecular events underlying and CMPs, but not in lymphoid progenitors. In contrast,
physiological lineage decisions at defined stages of he- a vast majority of lymphoid genes were expressed in
matopoiesis. We recently identified progenitor popula- CLPs, but not in HSCs or myeloid progenitors. CMPs
tions located downstream of HSCs by using a multi- expressed all GM- and MegE-affiliated genes, whereas
color fluorescence-activated cell-sorter (FACS) system CLPs expressed all T and B lymphoid genes. GMPs and
(Akashi et al., 2000a; Kondo et al., 1997). These functionally MEPs, the progenitors downstream of CMPs, shut off
and phenotypically distinct populations include common the expression of some of MegE-affiliated genes
myeloid progenitors (CMPs), common lymphoid progeni- (-globin and GATA-1) and GM-affiliated genes (MPO
tors (CLPs), granulocyte/monocyte progenitors (GMPs), and C/EBP), respectively. Similarly, proB and proT cells
and megakaryocyte/erythrocyte progenitors (MEPs). In downregulated the expression of T and B lymphoid
this report, we demonstrate that the promiscuous tran- genes, respectively. Accordingly, among genes tested,
scription of multiple hematopoietic differentiation pro- myeloid but not lymphoid genes (except for GATA-3)
grams occurs at initial stages of myeloid and lymphoid are expressed in HSCs, while lineage-affiliated genes
pathways, such as CMPs and CLPs, respectively. Thus, were reciprocally regulated at downstream branch-
myeloid or lymphoid promiscuity exists in early hemato- points for myeloid versus lymphoid, GM versus MegE,
poiesis, perhaps reflecting the selective opening of and T versus B lymphoid differentiation. We thus tested
chromatin domains characteristic for each stage of he- coexpression of GM- and MegE-affiliated genes in HSCs
matopoiesis. and CMPs and coexpression of T and B lymphoid genes
in CLPs at the single-cell level. The multiplex single-cell
RT-PCR analysis we employed was composed of threeResults
different sets of lineage-affiliated genes (Figure 1B).
Cells used for this series of experiments included long-
term hematopoietic stem cells (HSCs: LinCD34Thy1. Single CMPs Coexpress GM-
and MegE-Associated Genes1loSca-1c-Kit) (Morrison and Weissman, 1994; Osawa
et al., 1996), common myeloid progenitors (CMPs: Lin We first evaluated the changes in expression of GM-
and MegE-affiliated genes in the myeloid pathway fromSca-1c-KitFcRII/IIIloCD34), granulocyte/monocyte
progenitors (GMPs: LinSca-1c-KitFcRII/IIIhiCD34), HSCs at a single-cell level (Table 2; Figure 2A). Cells
expressing MPO and/or granulocyte colony-stimulatingmegakaryocyte/erythrocyte progenitors (MEPs: Lin
Sca-1c-KitFcRII/IIIloCD34) (Akashi et al., 2000a), factor receptor (G-CSFR) but neither -globin nor eryth-
ropoietin receptor (EpoR) were classified into the GMcommon lymphoid progenitors (CLPs: LinIL-7RSca-
1loc-Kitlo) (Kondo et al., 2000), proB cells (B220NK1.1 profile, and cells expressing -globin and/or EpoR but
neither MPO nor G-CSFR were classified into the MegECD43IgM), and proT cells (LinCD25c-Kit thymo-
cytes) (Akashi et al., 2000b; Hardy et al., 1991). In our profile. Cells expressing at least one GM- as well as
one MegE-affiliated gene were regarded as having thehands, 85% of HSCs, 95% of CMPs and GMPs, and
70% of MEPs respond in vitro to a full cocktail of promiscuous profile. Since all of these lineage-affiliated
genes appeared to be gradually upregulated from themyeloid cytokines by forming the appropriate hemato-
poietic colonies (Akashi et al., 2000a), and at least 30% HSC to CMP stages, cells expressing none of these
genes were classified into the primitive profile.of mice competitively reconstituted with single HSCs
exhibited donor-derived long-term multilineage recon- As shown in Table 2, 95% of GMPs and MEPs exhib-
ited GM and MegE profiles, respectively. Strikingly, 47%stitution (I.L.W. et al., unpublished data). All populations
were rigorously purified by multicolor FACS and were of single CMPs had the promiscuous phenotype, and
39% of CMPs coexpressed all of four granulocyte/ery-triple sorted in order to obtain the highest purity possible
(Miyamoto et al., 2000). Figure 1A summarizes the loca- throid-specific genes tested. A majority of the remaining
CMPs exhibited the GM profile, showing that CMPs aretion of these purified progenitors in normal steady-state
hematopoiesis. The lineage relationship of these pro- composed mainly of progenitors having promiscuous
and GM profiles. This is compatible with the functionalgenitors suggests that the first commitment decision
Lineage Promiscuity in Hematolymphopoiesis
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Figure 1. Differential Expression of Lineage-Affiliated Genes in Myeloid and Lymphoid Differentiation Pathways
(A) Lineage relationships of prospectively purified lineage-restricted progenitors in steady-state hematopoiesis. HSC, hematopoietic stem
cells; CMP, common myeloid progenitors; CLP, common lymphoid progenitors; GMP, granulocyte/monocyte progenitors; MEP, megakaryocyte/
erythrocyte progenitors.
(B) Results of nested RT-PCR analyses targeted for 200 progenitors each by using three sets of PCR primers and amplifying conditions
employed in single-cell RT-PCRs. Results are consistent with single-cell RT-PCR data summarized in Tables 2–4. Thus, whenever genes were
detectable by RT-PCRs from 200 cells, at least some single cells from the same fraction turned out to be positive as well.
analyses of phenotypically-purified CMPs in our previ- In myeloid set 2, both Lmo2 and GATA-2 play a critical
role in primary hematopoiesis, and depletion of eitherous study (Akashi et al., 2000a). In contrast, HSCs pre-
dominantly exhibited the primitive profile (41%), while molecule results in early embryonic death (Tsai et al.,
1994; Warren et al., 1994; Yamada et al., 1998). NF-E2they also contained cells of other profiles, including the
promiscuous profile (16%) (Table 2). is important for erythroid/megakaryocyte development
Table 1. Distribution of Lineage-Affiliated Genes in Purified Stem and Progenitor Cells
Presence of Transcripts
Lineage Genes Tested HSC CMP GMP MEP CLP ProB ProT
Myeloid
(GM) MPO       
G-CSFR       
M-CSFR       
CEBP       
(MegE) -globin       
EpoR       
c-mpl       
GATA-1       
GATA-2       
NF-E2       
(GM and MegE) IL-3R       
GM-CSFR       
Lymphoid
(T) CD3       
pT       
GATA-3       
(B) VpreB       
5       
Pax-5       
(T and B) Aiolos       
IL-7R       
Myeloid and lymphoid
PU.1       
c-myb       
Results of conventional RT-PCRs targeted for RNA purified from 200–500 purified cells. This table includes previously reported data (Akashi
et al., 2000a; Mebius et al., 2001). Genes listed in the table are categorized by their known functions and expression patterns as indicated.
GM, granulocyte/monocyte; MegE, megakaryocyte/erythrocyte.
Developmental Cell
140
1999), and 5 (Sakaguchi and Melchers, 1986) is anTable 2. Single-Cell RT-PCR Analysis of Myeloid Genes in
essential component for pre-B cell receptor formationPurified Myeloid Progenitors
(Karasuyama et al., 1994).
Percentage of Expression-
The vast majority of single proB cells expressed 5Positive Cells
and Pax-5, but not GATA-3 or CD3 (the proB profile),
Profile Classification HSC CMP GMP MEP and the earliest thymic precursors and proT cells (Wu
et al., 1991) expressed GATA-3 and CD3, but not 5GM profile (-globinEpoR)
MPOG-CSFR 18 41 91 0 or Pax-5 (the proT profile), whereas HSCs do not express
MPO or G-CSFR 13 5 4 0 any of these genes except for GATA-3 (Table 4; Figure
2C). In contrast, CLPs consisted of cells exhibiting all31 46 95 0
of these profiles; 31% of CLPs were of the proB profile,
MegE profile (MPOG-CSFR)
15% of CLPs were of the proT profile, and, interestingly,-globinEpoR 4 1 0 89
21% of CLPs coexpressed T and B lymphoid genes (the-globin or EpoR 8 1 0 6
promiscuous profile). The remaining 33% of CLPs did
12 2 0 95
not express any of these genes, nor did the vast majority
Promiscuous profile of HSCs (the primitive profile). Taken together, these
MPOG-CSFR-globinEpoR 6 39 0 0 data indicate that upregulation of lymphoid genes is
Positive for three of these genes 10 8 5 5
initiated at the CLP stage and that at least a fraction of
16 47 5 5 CLPs coexpress both T and B lymphoid genes.
Primitive profile (no expression) 41 5 0 0
Megakaryocyte/Erythrocyte Lineage PotentialOne hundred eighty-four to 460 single cells of each population were
Is Maintained in CMPs with Activatedanalyzed in the myeloid set 1.
M lysozyme Locus
We wished to acquire functional evidence that promis-
cuous gene expression precedes commitment to the
and/or survival (Romeo et al., 1990; Shivdasani et al., myeloid lineage by showing that this does not impair
1995). PU.1 is a master transcription factor for myelomo- the cell’s differentiation potential. Since M lysozyme is
nocytic as well as B cell development and/or survival. one of the major myelomonocyte-specific proteins
Mice lacking PU.1 exhibit defects in monocyte, granulo- (Cross et al., 1988), we used mice harboring an en-
cyte, and B and T cells (McKercher et al., 1996; Scott hanced green fluorescent protein (EGFP) reporter
et al., 1994), suggesting that PU.1 may play a critical knocked in to the murine M lysozyme (lys) locus (Faust
role in the GMP and CLP stages. According to the known et al., 2000) to obtain progenitors with active expression
functions of each transcription factor, we classified the of the gene. In the lys-EGFP mice, the level of GFP
expression pattern into four profiles: GM profile, expression reflects that of transcription of the endoge-
PU.1NF-E2; MegE profile, PU.1NF-E2; promiscu- nous M lysozyme, and, as a result, virtually all myelomo-
ous profile, PU.1NF-E2; primitive profile, negative for nocytic cells (neutrophils and monocytes) are GFP posi-
both PU.1 and NF-E2 (Table 3; Figure 2B). Again, more tive, while other hematopoietic lineages are mostly
than 50% of CMPs exhibited the promiscuous pheno- negative (Faust et al., 2000). It has previously been
type, whereas 90% of MEPs fit into the MegE profile, shown that deletion of endogenous M lysozyme does
and 52% of GMPs fit into the GM profile. Forty-two not affect hematopoietic development (Faust et al.,
percent of single GMPs unexpectedly fit into the primi- 2000). Figure 3A shows the expression levels of GFP
tive profile, probably because PU.1 begins to be down- in each purified progenitor population, and Figure 3B
regulated at the GMP stage. Accordingly, the coexpres- shows RT-PCR results for M lysozyme expression in
sion of multiple transcription factors affiliated with normal progenitors. The number and frequency of my-
different myeloid-erythroid fates is found most fre- eloid and lymphoid progenitors in lys-EGFP mice were
quently at the CMP stage. identical to normal mice (data not shown). The level of
In both myeloid sets 1 and 2, HSCs predominantly GFP in mature granulocytes was extremely high (beyond
exhibited the primitive profile, but a significant fraction the upper scale of the cytometer), whereas lymphocytes
of HSCs also possessed the promiscuous profile. Thus, were completely negative, indicating that this system is
these data strongly suggest that both GM- and MegE- a very sensitive reporter for the activation of the lys
affiliated programs begin to be transcribed at the level gene. M lysozyme expression is initiated at the HSC
of HSCs and are promiscuously upregulated at the CMP stage, as is the expression of other genes (data not
stages. shown). In the myeloid pathway, 62% of CMPs ex-
pressed a significant level of GFP. GMPs expressed
an 5-fold-higher median level of GFP than did CMPs,Single CLPs Coexpress Both T
and B Lymphoid Genes whereas the GFP level declined at the MEP stage (Figure
3A). In the lymphoid pathway, 1%–5% of CLPs andThe lymphoid PCR primer set was then applied to HSCs
and lymphoid progenitors. GATA-3 is required for the proT cells expressed minimal levels of GFP, but preT
and preB cells were completely GFP negative (data notdevelopment and/or survival of T cell-committed precur-
sors (Ho et al., 1991; Ting et al., 1996). CD3 is one of shown). These data were consistent with those from RT-
PCR analyses on purified normal progenitors (Figurethe components of TCR (van den Elsen et al., 1985).
Pax-5 plays a critical role in the early and late stages 3B). Both GFP and GFP CMPs expressed erythroid
-globin (data not shown). The purified GFP and GFPof B cell differentiation (Horcher et al., 2001; Nutt et al.,
Lineage Promiscuity in Hematolymphopoiesis
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Figure 2. Multiplex Single-Cell RT-PCR Analysis Demonstrates the Existence of Lineage Promiscuity in CMPs and CLPs
(A) Representative data for EpoR, -globin, G-CSFR, and MPO in single myeloid progenitors. The GM, MegE, promiscuous, and primitive
profiles are indicated as blue, red, yellow, and white open rectangles, respectively (see Table 2). Cells of the promiscuous profile are most
frequently found in CMPs.
(B) Representative data for NF-E2, GATA-2, Lmo2, and PU.1 in single myeloid progenitors. The GM, MegE, promiscuous, and primitive profiles
are indicated as blue, red, yellow, and white open rectangles, respectively (see Table 3).
(C) Representative data for 5, Pax-5, GATA-3, and CD3 in single lymphoid progenitors. ProT, proB, promiscuous, and primitive profiles are
indicated as blue, red, yellow, and white open rectangles, respectively (see Table 4). Cells of promiscuous profile are exclusively found in
CLPs. The percentages of each profile are summarized in Tables 2–4.
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transgenic mice in which a transgene containing a 9 kbTable 3. Single-Cell RT-PCR Analysis of Transcription Factors
fragment spanning all characterized pT promoter andin Purified Myeloid Progenitors
enhancer sequences is used to drive expression of an
Percentage of Expression-
hCD25 minigene. In pT-hCD25 transgenic mice, thePositive Cells
expression of hCD25 is highly correlated with that of
Profile Classification HSC CMP GMP MEP the endogenous pT, quantified by real-time RT-PCR
GM profile (PU.1NF-E2) 24 27 52 0 analyses (Gounari et al., 2002).
In the pT-hCD25 transgenic bone marrow, hCD25MegE profile (PU.1NF-E2) 3 13 1 90
expression was found not in HSCs, but in 7% of CLPs,
Promiscuous profile (PU.1NF-E2) 27% of TPs, and 74% of proT cells. hCD25 expression
Lmo2 and/or GATA-2 17 51 5 8
was found in only 1% of proB cells and was absent inLmo2GATA-2 0 3 0 0
preB cells (Figure 4A). All hCD25 cells in Lin fraction
17 54 5 8 expressed IL-7R, and a majority of these LinIL-7R
Primitive profile (PU.1NF-E2) cells expressed Sca-1 and c-Kit at low levels, represent-
Lmo2 and/or GATA-2 33 6 1 2 ing the CLP phenotype (Figure 4B). These data indicate
No expression 23 0 41 0 that pT expression in bone marrow begins at the CLP
56 6 42 2 stage. The expression level of hCD25 was highest in
proT cells and almost 8-fold less in CLPs at their medianOne hundred eighty-four to 368 single cells of each population were
levels within hCD25 fractions (Figure 4A). In contrast,anlayzed in the myeloid set 2.
hCD25 expression was undetectable in myeloid progen-
itors, such as CMPs, GMPs and MEPs (data not shown).
Therefore, the expression levels, as well as frequencies,
CMPs were tested for their lineage potentials by in vitro of endogenous pT appears to increase along the T cell
colony assays (Akashi et al., 2000a). As shown in Figure differentiation pathway initiated from CLPs but rapidly
3C, megakaryocyte/erythrocyte differentiation was de- declines along the B cell differentiation pathway. PCR
tectable in 40% of CMP populations, irrespective of analysis showed that only the hCD25 population of
GFP expression. These data directly demonstrate that each progenitor subset expressed pT at detectable
the expression of M lysozyme at a low level occurs at levels (Figure 4C). Furthermore, 81% of single hCD25
the CMP stage prior to commitment to the GM lineage CLPs and 98% of single hCD25 proT cells expressed
and that this does not impair their viability nor does it detectable levels of pT by single-cell RT-PCR analyses
mark their commitment to myelomonocytic fates. (data not shown).
We next analyzed the expression of lymphoid genes
in hCD25 CLPs and found that the expression of 5,B Cell Potential Is Maintained in CLPs
Pax-5, CD3, and GATA-3 did not significantly differ,with Activated Transcription of Pre-T Cell
irrespective of hCD25 expression in CLPs (Table 4). WeReceptor  Chain
then evaluated B cell differentiation potential in hCD25To obtain functional evidence for the involvement of
CLPs on S17 stromal cells (Kondo et al., 1997). As shownlineage promiscuity in lymphoid lineage, we prospec-
in Figure 4D, hCD25 CLPs differentiated into mature Btively purified CLPs expressing the T lymphoid pre-T
cells in vitro, and the frequency of B cell development didcell receptor  chain (pT). The pT protein pairs with
not significantly differ on the basis of hCD25 expression.a TCR  chain to form the pre-TCR (Groettrup et al.,
These data indicate that the expression of pT does not1993), which plays a critical role in the efficient genera-
tion of mature T cells (Fehling et al., 1995). We analyzed mark T cell commitment at the CLP stage.
Table 4. Single-Cell RT-PCR Analysis of Lymphoid Genes in Purified Lymphoid Progenitors
Percentage of Expression-Positive Cells
Profile Classification HSC CLP pT CLP TP ProT ProB
ProT profile (Pax-55)
GATA-3 and/or CD3 9 15 16 62 87 0
ProB profile (GATA-3CD3)
Pax-5 and/or 5 0 31 26 0 0 100
Promiscuous profile
Pax-55GATA-3CD3 0 4 8 0 0 0
Pax-55GATA-3CD3 0 13 12 0 0 0
Pax-55GATA-3CD3 0 4 4 0 0 0
0 21 24 0 0 0
Primitive profile (no expression) 91 33 34 38 13 0
One hundred eighty to 450 single cells of each population were analyzed in the lymphoid set. TP, the earliest thymic precursors. pT CLPs
were purified from hCD25-pT transgenic mice (see text).
Lineage Promiscuity in Hematolymphopoiesis
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Figure 3. Functional Analysis of Progenitors with Activated M lysozyme Gene Locus in lys-EGFP Knockin Mice
(A) Expression of GFP in purified myeloid and lymphoid progenitors. Note that 60% of CMPs were GFP; this increases along the GM
differentiation (GMPs to Gr-1 granulocytes) and rapidly downregulates along the MegE differentiation (MEPs). B cells are completely negative
for GFP.
(B) Semiquantitative RT-PCR analyses of M lysozyme gene expression in FACS-purified normal progenitors (Akashi et al., 2000a). The symbols
under each lane depict relative amounts of mRNA in each population compared to control cDNA (2 	 105 cells—bands not shown) by the
ratio pixel density units of target cDNA/pixel density units of control cDNA:
0.1 (), 0.1–0.5 (), 0.5–1.5 (), and 1.5 (). Gra, granulocytes.
(C) Functional myeloid readouts from single CMPs with activated or inactivated M lysozyme. The GFP and GFP CMPs contained a similar
combination of myeloid (GM, MegE, and Mix) colony-forming units (CFUs) in a methylcellulose assay.
Discussion appears in CLPs, whose B cell potential as well as ex-
pression profiles of T and B lymphoid genes are un-
changed, irrespective of pT transcription. Accordingly,In this paper, we provide direct evidence that multiple
the expression of lineage-affiliated genes precedeslineage-affiliated differentiation programs are promiscu-
commitment and does not bias the cells’ differentiationously activated at the transcriptional level prior to com-
potential. It has also been reported that transcriptionalmitment during hematopoiesis. Our data show that (1)
activation of a subunit of the platelet integrinIIb3 locuslymphoid as well as myeloid promiscuity operates in
(Tronik-Le Roux et al., 2000; Tropel et al., 1997) and aearly hematopoiesis, (2) lineage promiscuity is most pro-
-globin promoter (Papayannopoulou et al., 2000) cannounced in oligopotent CMPs and CLPs that actively
occur at the level of myeloerythroid progenitors. Basedcontribute to physiological hematopoiesis, and (3) lin-
on these data, myeloid and lymphoid promiscuity mighteage promiscuity does not alter the lineage potential of
operate as a critical mechanism for physiological hema-oligopotent progenitors.
topoietic lineage commitment.Lineage-promiscuous expression demonstrated in
It is important to note that the expression level of Mour study might be linked to the lineage potential of
lysozyme and pT is relatively low in CMPs and CLPs,each cell type. In our hands, 60% of single CMPs
respectively. We have also reported that myeloid genes
can generate secondary GM and MegE colonies, and a
(i.e, EpoR, MPO, and NF-E2), and lymphoid genes (i.e.,
majority of the remaining CMPs can generate only GM Pax-5, GATA-3, and Aiolos) are expressed at relatively
colonies (data not shown), similar to the result in trans- low levels (10-fold less) in CMPs and CLPs, respectively,
genic Bcl-2-expressing CMPs (Akashi et al., 2000a). The when compared to their progeny (Akashi et al., 2000a;
distribution of promiscuous and GM expression profiles Mebius et al., 2001). Such low-level gene expression
within the CMP population is consistent with this func- may not cross threshold levels to cause commitment
tional data. Since the efficiency for colony formation toward a particular fate within each progenitor potential.
from CMPs is more than 95% (Akashi et al., 2000a), it Thus, it seems most likely that it is the combinatorial
is highly likely that CMPs of promiscuous profile possess quenching of inappropriate, and upregulation of appro-
both GM and MegE differentiation potentials. Further- priate, gene expression programs that stabilizes the se-
more, we showed directly that CMPs can differentiate lection of specific sublineages (Enver and Greaves,
into MegE lineage cells, irrespective of activation of the 1998). Furthermore, it is possible that expression pro-
M lysozyme gene. Single CLPs also coexpress T and B files of genes we presented may merely reflect a “snap-
shot” of each progenitor subset. It is of interest to evalu-lymphoid genes. The expression of the pT gene first
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Figure 4. Functional Analysis of pT-Expressing Lymphoid Progenitors in pT-hCD25 Transgenic Mice
(A) Expression of hCD25 in purified HSCs, CLPs, the earliest thymic precursors (TPs), and proB and proT cells in pT-hCD25 transgenic mice.
(B) In the lineage-negative bone marrow, hCD25 cells are exclusively found in IL-7R fraction (left); a majority of the cells possess the CLP
phenotype (Sca-1loc-Kitlo) (right).
(C) Correlation of hCD25 expression with endogenous pT expression. One thousand cells of hCD25 or hCD25 purified HSCs, CLPs, and
proT and proB cells are analyzed for pT expression by RT-PCRs. The expression of endogenous pT is observed only in hCD25 fraction
of each lymphoid progenitor subset.
(D) B cell differentiation from pT or pT CLPs. hCD25 CLPs differentiate into CD19IgM mature B and CD19IgM preB cells, but not
myeloid cells (left). In a limit dilution analysis, we estimate that one in six hCD25 CLPs and one in seven hCD25 CLPs can read out B cell
differentiation in this culture condition (right), indicating that CLPs possess B cell potentials, irrespective of pT expression.
ate whether the expression of genes is fluctuated Furthermore, control of gene expression programs
might be modulated by changes in levels of key tran-(Grosveld et al., 1998) at the lineage-promiscuous
stages, such as by cell division or extrinsic signals scription factors (DeKoter and Singh, 2000; Kulessa et
al., 1995). Cross-talk between different cytokine recep-(Cross and Enver, 1997; Enver and Greaves, 1998).
It remains unclear whether the primary mechanism of tors may also occur, since single progenitors coexpress
multiple lineage-related cytokine receptors. Thus, fluc-hematopoietic commitment could be operated first by
opening chromatin at programmed sites or whether the tuations of gene expression of multiple differentiation
programs in progenitors (which includes cytokine recep-priming seen in promiscuous transcription patterns re-
sults from the presence of open chromatin and tran- tors) may lead to different differentiation outcomes de-
pending on whether or not a specific cytokine is presentscription factors that can form sterile transcripts. It is
reasonable to assume that, in promiscuous stages of in the microenvironment. In this view both intrinsic (sto-
chastic) and extrinsic (deterministic) factors could playhematopoietic development, multiple gene programs
transcribing at low levels collaborate or compete with a role in lineage determination.
Whether stochastic or deterministic, the expressioneach other until one becomes dominant. In this process,
there should be significant cross-talk among transcrip- of “lineage-specific” differentiation programs prior to
commitment might reflect lineage potentials, whereastion factors or transcriptional complexes. For example,
transcription factor activity can be potentiated (Tsang loss of promiscuous gene expression might correlate
with their commitment to terminal differentiation. How-et al., 1997) or suppressed (Sieweke et al., 1996; Zhang
et al., 2000) by interaction with other transcription fac- ever, abrogated differentiation programs for unselected
lineages might not be totally erased after the completiontors. In lymphoid versus myeloid progenitors, adult CLPs
express a low level of Pax-5 that might suppress the of commitment but could be reactivated by “instructive”
signals, as committed progenitors can be occasionallydifferentiation program toward myelomonocytic lin-
eages (Chiang and Monroe, 1999; Mebius et al., 2001). reprogrammed to unrelated lineages. For example, we
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recombination to insert the EGFP gene into the M lysozyme (lys)have reported that ectopic IL-2R or GM-CSFR signals
locus (Faust et al., 2000). To maximize the GFP expression, miceinto CLPs can reprogram the cells to myelomonocytic
homozygous for lys-EGFP were used for this study.transdifferentiation (Kondo et al., 2000). In this case, the
reactivation of myeloid-related genes, including C/EBP
Cell Staining and Sorting
and GATA-1, occurs as soon as cells are reprogrammed For sorting myeloid progenitors, bone marrow cells were stained
into the myelomonocytic lineage (H.I. et al., unpublished with biotinylated rat anti-IL-7R chain (A7R34), anti-Thy-1.1 (19XE5),
data). Although myeloid and lymphoid promiscuity may and rat antibodies specific for the following lineage markers: CD3
(KT31.1), CD4 (GK1.5), CD8 (53-6.7), B220 (6B2), Gr-1 (8C5), TER119,independently exist in physiological hematopoiesis, the
CD19 (1D3), and IgM (R6-60.2) (Pharmingen, San Diego, CA). IL-plasticity of lineage-affiliated differentiation programs
7RThy-1.1Lin cells were removed with sheep anti-rat IgG-may cause lineage-overlapping “mixed” phenotypes in
conjugated magnetic beads (Dynabeads M-450; Dynal A.S., Oslo,
hematological malignancies (Greaves et al., 1986; Norway), and the remaining cells were stained with avidin-PE-Cy5
McCulloch, 1987; Akashi et al., 1991) that can originate (Tricolor) (Caltag, Burlingame, CA). Cells were then stained with
from hematopoietic progenitors (Traver et al., 1998; PE-conjugated anti-FcRII/III (2.4G2), FITC-conjugated anti-CD34
(RAM34) (Pharmingen), Texas red (TR)- or APC-Cy7-conjugatedYuan et al., 2001).
anti-Sca-1 (E13-161-7), and APC-conjugated anti-c-Kit (2B8) mono-In our analysis, HSCs express a variety of combina-
clonal antibodies. Myeloid progenitors were sorted as LinSca-1c-tions of MegE- and GM-affiliated genes, but not
KitCD34FcRII/IIIlo (CMPs), LinSca-1c-KitCD34FcRII/IIIhi
lymphoid genes. The similar phenomenon has been re- (GMPs), and LinSca-1c-KitCD34FcRII/IIIlo (MEPs) as de-
ported in progenitors in the AGM region (Delassus et scribed previously (Akashi et al., 2000a). For sorting HSCs and CLPs,
al., 1999). Although the number of lymphoid genes ana- we stained bone marrow cells with lineage markers as well as FITC-
conjugated anti-Thy-1.1, biotinylated anti-IL-7R, TR- or APC-CY7-lyzed in these studies was limited, we recently found
conjugated anti-Sca-1, and APC-conjugated anti-c-Kit antibodiesthat a vast majority of lymphoid genes are not expressed
followed by PE-conjugated streptavidin (Caltag). HSCs and CLPsin HSCs by a genome-wide microarray analysis, which
were sorted as LinSca-1hic-KithiThy-1.1loIL-7R and LinSca-1loc-
covers more than 150 lymphoid-specific genes (K.A. et KitloThy-1.1IL-7R populations, respectively. A majority of LinSca-
al., unpublished data). Thus, although it is still unclear 1hic-KithiThy-1.1loIL-7R HSCs are CD34/lo in our hands (data not
whether HSCs with myeloid promiscuity have the HSC shown). Thymic progenitors, proT cells, and proB cells were sorted
as CD3CD4CD8NK1.1c-KitCD25CD44, CD3CD4CD8functions, it is possible that the myeloid gene expression
NK1.1c-KitCD25CD44, and CD43B220IgMNK1.1 cells, re-program is a default pathway and that triggering lymphoid
spectively.commitment requires activation of additional sets of
Cells were sorted using a highly modified triple-laser (488 nm
genes. This phenomenon may reflect both evolution and argon laser, 599 nm dye laser, and UV laser) FACS (FACS Vantage;
ontogeny, since macrophage-erythroid-like cells pre- Becton Dickinson Immunocytometry Systems, Mountain View, CA)
cede lymphoid cell formation during evolution (Hansen or a double-laser (488 nm/350 nm Enterprise II plus 647 nm Spec-
trum) high-speed FACS (Moflo-MLS; Cytomation, Fort Collins, CO).and Zapata, 1998). It is also reported that first hemato-
poietic cells that arise during embryonic development
Analysis of Gene Expression from Total RNAhave the potential to produce primitive erythroid cells as
First-strand cDNA was synthesized from total RNA from 100 towell as macrophages but appear to be devoid of lymphoid
1000 cells of each population with gene-specific reverse primer.
cell-forming potential (Cumano and Godin, 2001). Thereafter, cDNA was amplified for 36 cycles consisting of 94C for
Thus, low-level transcriptional activation of lineage- 30 s, 60C for 60 s, and 72C for 120 s with gene-specific forward
specific differentiation programs precedes commitment primers. Four percent aliquots of the first-round PCR products were
added to the second PCR reaction, and the nested PCR with 32to a particular lineage. The promiscuous expression of
cycles was carried out using fully nested gene-specific primers.multiple lineage-affiliated genes involved in HSCs and
PCR products were subjected to gel electrophoresis and visualizedintermediate progenitors may be a requirement for
by ethidium bromide staining.
multipotent cells to maintain their lineage potentials.
Furthermore, lineage promiscuity in early progenitors
Analysis of Single Cells by RT-PCR
may reflect a general property of stem cells, since over- Multiplex single-cell RT-PCR analysis was performed principally ac-
lapping genetic programs between hematopoietic and cording to the method by Hu et al. (Hu et al., 1997) with minor
modifications. Briefly, triple-sorted single cells were deposited intoneural stem cells have been reported (Terskikh et al.,
three separate 96-well reaction plates (MicroAmp; Applied Biosys-2001), and HSCs express a variety of genes related to
tems, Foster City, CA) containing lysis buffer (0.5% Triton X-100) andnonhematopoietic tissues (K.A. et al., unpublished data).
reverse transcription buffer. Cell lysates were reverse-transcribedUndertaking detailed profiling of lineage-affiliated genes
using five pairs of gene-specific reverse primers. The first-round
at each stage of development should thus be useful to PCR was subsequently performed in the same plate by the addition
evaluate immediate lineage potentials of both hemato- of premixed PCR buffer containing the gene-specific forward and
reverse primers. Four percent of aliquots of the first-round PCRpoietic and nonhematopoietic stem and progenitor cells.
reactions were replica plated into new PCR reaction plates for the
second round of PCR, which was carried out separately for eachExperimental Procedures
gene with fully nested gene-specific primers. Aliquots of second-
round PCR products were subjected to gel electrophoresis. SinceMouse
C57BL6/Ka-Thy1.1 mice, pT-hCD25 mice, and lys-EGFP mice the primers are designed to span at least one intron, genomic prod-
ucts can be excluded by the larger size. The sequences of external(Faust et al., 2000) were used in this study. Mice were bred and
maintained in the Research Animal Facility at Stanford University and internal oligonucleotide primers for each gene will be provided
on request.School of Medicine, Dana-Farber Cancer Institute, and Albert Ein-
stein College of Medicine in accordance with guidelines in each One hundred Linc-Kit cells were used as positive controls in
the myeloid plates. All of the genes examined in this study werefacility. The pT-hCD25 transgenic mice are homozygous for a
transgene containing 9 kb of the mouse pT upstream region (Reizis detectable in the positive control, since this population contains all
three subsets of myeloid progenitors as well as HSCs (Akashi et al.,and Leder, 1999) driving the expression of the hCD25 (Gounari et
al., 2002). The lys-EGFP mice were obtained by using homologous 2000a). As a positive control in the lymphoid plate, 100 proB and
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proT cells were used. Around 90% of single cell-deposited wells Enver, T., and Greaves, M. (1998). Loops, lineage, and leukemia.
Cell 94, 9–12.yielded successful HPRT amplification, and results from HPRT-posi-
tive wells were counted. Fairbairn, L.J., Cowling, G.J., Reipert, B.M., and Dexter, T.M. (1993).
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